Biofilm inhibitory and eradicating activity of wound care products against<i>Staphylococcus aureus</i>and<i>Staphylococcus epidermidis</i>biofilms in an<i>in vitro</i>chronic wound model

Abstract

Our model can be used to compare the efficacy of wound care products to inhibit biofilm formation and/or eradicate mature biofilms. In addition, the results indicate that treatment of infected wounds should be started as soon as possible and that novel products with more potent antibiofilm activity are needed.